Lysine-Specific Demethylase 1 (LSD1/KDM1A) Inhibition as a Target for Disease Modification in Myelofibrosis

Myelofibrosis (MF) is the most symptomatic form of myeloproliferative neoplasm and carries the worst outcome. Allogeneic hematopoietic stem cell transplantation is the only therapy with potential for cure at present, but is limited by significant mortality and morbidity. JAK inhibition is the mainst...

Descripción completa

Detalles Bibliográficos
Autor principal: Gill, Harinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265913/
https://www.ncbi.nlm.nih.gov/pubmed/35805191
http://dx.doi.org/10.3390/cells11132107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265913/
https://www.ncbi.nlm.nih.gov/pubmed/35805191
http://dx.doi.org/10.3390/cells11132107

Ejemplares similares